Treatment of thromboembolic disease during pregnancy and in paediatrics;Tratamiento de la enfermedad tromboembólica durante la gestación y en pediatría

Angiologia

Volumn 55, Issue 2, 2003, Pages 94-99

  Zuazu Jausoro, Isabel ^a   Perez Ceballos E ^a   Candela Garcia M J ^a   Lozano, M L ^a  

^a HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; C REACTIVE PROTEIN; DALTEPARIN; ENOXAPARIN; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; TINZAPARIN; VON WILLEBRAND FACTOR;

ANTICOAGULANT THERAPY; CONFERENCE PAPER; FEMALE; HUMAN; HYPERCOAGULABILITY; PRACTICE GUIDELINE; PREGNANCY; THROMBOEMBOLISM; THROMBOSIS PREVENTION; VENOUS STASIS;

EID: 0038341990     PISSN: 00033170     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-3170(03)79306-7     Document Type: Conference Paper

References (7)

1. Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost 2001; 86: 104-11.
2. Greer IA. Trombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353: 1258-65.
3. Bazzan M, Donvito V. Low molecular weight heparin during pregnancy. Thromb Res 2001; 101: 175-86.
4. Zuazu MI, Pérez-Ceballos E, Vicente V. Heparinas de bajo peso molecular en la profilaxis del tromboembolismo venoso en situaciones especiales: gestación, pediatría y otras. In Heparinas de bajo peso molecular. Madrid: Acción Médica; 2001. p. 93-107.
5. Bates SM, Ginsberg JS. How we manage venous thromboembolism during pregnancy. Blood 2002; 100: 3470-8.
6. Dasí-Carpio MA. Trombosis y tratamiento antitrombótico en la infancia. Haematologica 2002; 87 (Suppl. 1): 5-11.
7. Brill-Edwards P, Ginsberg JS, Gent M. Safety of witholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this pregnancy study group. N Engl J Med 2002; 343: 1439-44.